Literature DB >> 6264409

ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve.

F L Strand, T T Kung.   

Abstract

Adrenocorticotropin (ACTH)-treated adrenalectomized rats subjected to crush denervation recover sensation and functional movement sooner than saline-treated rats. Axonal regeneration is accelerated, the number of large endplates and the frequency of preterminal branching are increased. ACTH has no effect on either intact or denervated muscles. The ameliorative action of ACTH during regeneration is apparently neurogenic and independent of corticoids.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6264409     DOI： 10.1016/0196-9781(80)90077-7

Source DB:  PubMed          Journal:  Peptides        ISSN： 0196-9781            Impact factor:   3.750


  13 in total

1.  Assessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.

Authors:  Amy Perrin Ross; June Halper; Colleen J Harris
Journal:  Int J MS Care       Date:  2012

2.  Cloning, expression, and tissue distribution of a fifth melanocortin receptor subtype.

Authors:  Z Fathi; L G Iben; E M Parker
Journal:  Neurochem Res       Date:  1995-01       Impact factor: 3.996

3.  Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy.

Authors:  B Bravenboer; P H Hendrikse; P L Oey; A C van Huffelen; C Groenhout; W H Gispen; D W Erkelens
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

4.  Ultrastructural study of effect of ACTH4-10 on nerve regeneration; axons become larger in number and smaller in diameter.

Authors:  W A Bijlsma; E van Asselt; H Veldman; F G Jennekens; P Schotman; W H Gispen
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

5.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 6.  FK506 and the role of immunophilins in nerve regeneration.

Authors:  B G Gold
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

7.  Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma.

Authors:  S Koeppen; C C P Verstappen; R Körte; M E Scheulen; D Strumberg; T J Postma; J J Heimans; P C Huijgens; B Kiburg; K Renzing-Köhler; H C Diener
Journal:  J Cancer Res Clin Oncol       Date:  2004-01-16       Impact factor: 4.553

8.  Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system.

Authors:  L Roselli-Rehfuss; K G Mountjoy; L S Robbins; M T Mortrud; M J Low; J B Tatro; M L Entwistle; R B Simerly; R D Cone
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

Review 9.  A review of the use of chemoprotectants in cancer chemotherapy.

Authors:  C Lewis
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

10.  Characterization of MSH/ACTH-like immunoreactivity in sciatic nerves of Xenopus laevis by immunocytochemistry, western blotting and radioimmunoassay.

Authors:  J E Tingstedt; J B Nielsen; L I Larsson
Journal:  Histochemistry       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.